---
title: "LIFEMD DEADLINE REMINDER: Bragar Eagel & Squire, P.C. Urges LifeMD Investors to Contact the Firm Before the October 27th Deadline"
description: "Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In LifeMD ( LFMD ) To Contact Him Directly To Discuss Their Options"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/261106029.md"
published_at: "2025-10-14T15:38:03.000Z"
---

# LIFEMD DEADLINE REMINDER: Bragar Eagel & Squire, P.C. Urges LifeMD Investors to Contact the Firm Before the October 27th Deadline

> Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In LifeMD ( LFMD ) To Contact Him Directly To Discuss Their Options

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In LifeMD ( LFMD ) To Contact Him Directly To Discuss Their Options

### Related Stocks

- [LFMD.US - LifeMD](https://longbridge.com/en/quote/LFMD.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| LifeMD Secures $50 Million Revolving Credit Facility from Citizens Bank | LifeMD Inc. has secured a $50 million revolving credit facility from Citizens Bank, which includes $30 million in commit | [Link](https://longbridge.com/en/news/271657692.md) |
| Lake Street Keeps Their Buy Rating on LifeMD (LFMD) | Lake Street's Ryan Meyers maintains a Buy rating on LifeMD with a price target of $8.00. The analyst, covering the Consu | [Link](https://longbridge.com/en/news/270855288.md) |
| LifeMD Chief Marketing Officer Jessica Friedeman Reports Sale of Common Shares | Jessica Friedeman, Chief Marketing Officer of LifeMD Inc., has reported the sale of common shares of the company. This i | [Link](https://longbridge.com/en/news/269437200.md) |
| LifeMD Delays Quarterly Financial Report Over Revenue Recognition Errors | LifeMD Inc. has delayed its Quarterly Report on Form 10-Q for the period ended September 30, 2025, due to the need for a | [Link](https://longbridge.com/en/news/265596760.md) |
| LifeMD (NASDAQ:LFMD) Releases Earnings Results, Misses Expectations By $0.04 EPS | LifeMD reported a quarterly EPS of ($0.10), missing the consensus estimate of ($0.06) by $0.04. The stock rose 2.2% to $ | [Link](https://longbridge.com/en/news/266438689.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.
